Who invested in Pulmocide

3 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$110Mraised across 3 rounds since 2013, from 3 sources

$28MSeries A$30MSeries B$52MSeries C

Latest round: Series C, $52MDec 2022
Step-upi: 1.7×
Investors: 9

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015201720192021

$28MSeries A$30MSeries B$52MSeries C

First round: Series A, $28M
Biggest round: $52M
Usual gap between rounds: 5.7 years

The rounds

Dec 2022
Series C$52M4 new
Source recorded
Mar 2017
Series B$30M1 returning
- SV Life Sciences
Reported by Techcitynews
Nov 2013
Series A$28M5 new
Reported by finsmes.com

Funding filed with regulators

Pulmocide filed 6 raises, $160M in all. Filings say how much was sold and to how many investors; they never name the investors.

Sept 2025$4.2MUK share allotment
Apr 2025$27MUK share allotment
Apr 2024$39MUK share allotment
Jan 2024$13MUK share allotment
Nov 2022$45MUK share allotment
Nov 2021$31MUK share allotment

Founders and team

From Pulmocide's own website: 16 on the team.

Dan BurgessChairman and Chief Executive Officer
Sonya Roeloffzen StokowskiVice President, Head of Global Regulatory Affairs
Dr. David MantusPresident, US Operations
Jennifer Giottonini CayerChief Business Officer and Head of Corporate Development
Ashish SagrolikarChief Commercial Officer
Dr. Lance BermanChief Medical Officer
Dr. Pete StrongChief Scientific Officer and Cofounder
Matt DallasChief Financial Officer
Dr. Alex PasteurBoard Member
Dr. Fiona MacLaughlinBoard Member
Dr. Sam WilliamsBoard Member
Jake NunnBoard Member
Jim MeyersBoard Member
Kabeer AzizBoard Member
Kate BinghamBoard Member
Sabine DandiguianBoard Member

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2013Series B2017Series C2022SV Life Sciences

F-Prime Capital

Vivo Capital

SR One

Johnson & Johnson Development Corporation (JJDC)SV Health InvestorsImperial Innovations Investment Management

Longwood FundFidelity Biosciences

Everyone who backed them

SV Life SciencesVC firm2rounds

F-Prime CapitalVC firm1round

Vivo CapitalPrivate equity1round

SR OneCorporate VC1round

Johnson & Johnson Development Corporation (JJDC)VC firm1round

SV Health InvestorsVC firm1round

Imperial Innovations Investment ManagementInvestment firm1round

Longwood FundVC firm1round

Fidelity BiosciencesInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Pulmocide as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Jeito CapitalVC firmPer its own site

Adjuvant CapitalVC firmPer its own site

Touchstone InnovationsVC firmPer its own site

Quick answers about Pulmocide

Who invested in Pulmocide?

Pulmocide's investors include SV Life Sciences, F-Prime Capital, Vivo Capital, SR One and Johnson & Johnson Development Corporation (JJDC), and 4 more on record.

How much has Pulmocide raised?

Pulmocide has raised $110M across 3 rounds since 2013.

When did Pulmocide last raise?

Pulmocide's most recent round was a Series C of $52M in Dec 2022.

What was Pulmocide's biggest round?

Its most recent round, $52M in Dec 2022, is also its largest on record.

Who backed Pulmocide first?

Pulmocide's first round on record, in Nov 2013, was backed by F-Prime Capital, SV Life Sciences and Johnson & Johnson Development Corporation (JJDC) and 2 others.